SMAD2 and colorectal carcinoma: CTBP1-AS2 was shown to be overexpressed in colorectal cancer by Li et al., and it enhances the activation of the TGF-/SMAD2/3 signaling pathway by blocking miRNA-93-5p, which in turn allows rapid progression of CRC [40].